Pricing Log in Create free account
Friday 6 November 2026 Export EXEL’s income statement to Excel — free account

Exelixis, Inc.

EXEL Healthcare Biotechnology

Exelixis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.98% from fiscal 2024.

Revenue
+10.2%
EPS
+22.2%
Free cash flow
−4.83%

Quarter to September 2026, against a year earlier

69.96 1.25 +1.82%
Market cap
$16.8B
P/E
19.9×
Fwd P/E
20.2×
Dividend yield
—
F-score
7/9
Altman Z
12.68
Beneish M
−2.61
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Exelixis, Inc. (EXEL) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Exelixis, Inc. (EXEL) trades at a P/S ratio of 6.8×. Over the past ten years it has ranged from 2.9× (October 2022) to 49.7× (September 2016); the current reading is higher than 54% of that period. That is below the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 5.1× 15.20%
FY2024 4.5× 7.06%
FY2023 4.2× 27.87%
FY2022 3.3× (18.90%)
FY2021 4.0× (35.97%)
FY2020 6.3× 13.72%
FY2019 5.5× (19.72%)
FY2018 6.9× (66.32%)
FY2017 20.4× 5.70%
FY2016 19.3× (39.28%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 5.8× 3.04%
Jun 2026 5.6× 20.11%
Mar 2026 4.7× (9.08%)
Dec 2025 5.1× 5.89%
43 more quarters

Against its own ten years

Low 2.9× High 49.7×
Ten-year median 6.2×
Current reading's percentile 59

P/S ratio against peers

Company P/S ratio
JAZZ Jazz Pharmaceuticals PLC compare 3.1×
ALNY Alnylam Pharmaceuticals, Inc. compare 4.2×
EXEL Exelixis, Inc. 6.8×
HALO Halozyme Therapeutics, Inc. compare 7.8×
BNTX BioNTech SE Sponsored ADR compare 7.9×
ASND Ascendis Pharma A/S compare 13.5×
BBIO BridgeBio Pharma, Inc. compare 15.5×
INSM Insmed, Inc. compare 15.6×
SMMT Summit Therapeutics PLC compare 15,884×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on EXEL